BioAtla, Inc. (BCAB) stock
BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.31−0.05 (-3.68%)
Close on Oct 19, 2026Market cap $2.18MP/E –Yield –
BioAtla price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
BioAtla's price to sales ratio was 406.8× on Jul 29, 2022.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jul 29, 2022 | 406.8× | – |
See a number that looks wrong?